FDA pilot offers generative AI medical devices a path to patients before they are authorized - STAT

The FDA is creating a fast-track program that allows AI-powered medical devices to reach patients before full regulatory approval. This matters to patients and professionals because it could speed up access to new treatments but also raises safety questions.